ImmunoPrecise Antibodies (IPA) Stock Analysis

What ImmunoPrecise Antibodies does

ImmunoPrecise Antibodies Ltd. (IPA) is a global biotechnology firm that, through its subsidiaries, focuses on the development and production of antibodies, alongside offering a broad spectrum of related scientific services. Its operational footprint spans across the United States, Canada, Europe, Australia, and other international territories. For the research community, IPA delivers a diverse portfolio of products, including various types of antibodies, enzymes, enzyme activity assays, specialized animal products for arthritis studies, proteins (such as deiminated proteins), organoid growth factors, and hybridoma reagents. As a comprehensive Contract Research Organization (CRO), IPA provides an extensive suite of services covering the entire antibody discovery and development pipeline. This includes customized antigen design, modeling, and manufacturing; advanced B cell analysis encompassing sorting, screening, and sequencing; the development and screening of custom, immune, and naive phage display libraries; multi-species antibody discovery, including from transgenic animals; and the creation of specialized antibody formats such as bi-specific, tri-specific, VHH, and VNAR (shark) antibodies. Further expertise lies in DNA cloning, protein and antibody downstream processing, label-free biosensor-based antibody characterization, and antibody engineering. They also provide transient and stable cell line generation, antibody optimization and humanization, high-throughput hybridoma production with multiplexed screening and clone selection, and cryopreservation services. The company actively engages in strategic research collaborations, notably partnering with Pierre Fabre S.A. for antibody discovery initiatives. Additionally, it collaborates with Elektrofi, Inc. to investigate a high-concentration formulation for its COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was established in 1983 and maintains its headquarters in Victoria, Canada.

Key metrics

ETFs linked to IPA

Broad-market and Healthcare sector ETFs an investor holding ImmunoPrecise Antibodies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how IPA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies trades under the ticker IPA on NASDAQ.

Which exchange is IPA listed on?

IPA is listed on NASDAQ.

What sector does ImmunoPrecise Antibodies operate in?

ImmunoPrecise Antibodies is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IPA in a portfolio?

PortView shows IPA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.